Our study is to evaluate the feasibility and reliability of perfusion quantitative parameters based on dynamic triple-phase enhanced CT in the diagnosis of lung lesions, to explore whether the parameters are related to the expression of VEGF and MVD, in order to seek a both safe and non-invasive method to evaluate the expression of VEGF and MVD in lung cancer. Here, VEGFA is linked to lung cancer.